戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 pha1beta2 and alpha1beta2gamma2 receptors to ginkgolides.
2  required for glycine receptor inhibition by ginkgolides.
3 onally, the antioxidants ginsenoside Rb1 and ginkgolide A effectively reversed HAART drug-induced vas
4 modulating Abeta oligomeric species, and (3) ginkgolide A has therapeutic potential for prevention an
5 ss is not the mechanism by which EGb 761 and ginkgolide A suppress Abeta-induced paralysis because th
6 port that EGb 761 and one of its components, ginkgolide A, alleviates Abeta-induced pathological beha
7         These acetyl derivatives, as well as ginkgolides A and B acetates have been investigated for
8                                         Both ginkgolides and bilobalide inhibit GABA(A) receptors, wi
9                         Terpene trilactones (ginkgolides and bilobalide) are unique constituents of G
10                     Their active components (ginkgolides and bilobalide) have structures similar to t
11              The terpene trilactones (TTLs), ginkgolides and bilobalide, are structurally unique cons
12 nd demonstrate a striking similarity between ginkgolides and picrotoxinin, a GABA(A) and recombinant
13 emonstrates a strong interaction between the ginkgolides and the 2' residue, a result supported by in
14                                              Ginkgolides are known antagonists of the platelet-activa
15                     We find that most of the ginkgolides are selective and potent antagonists of the
16                                              Ginkgolides are structurally unique constituents of Gink
17 n with the PAF inhibitors WEB 2086 (WEB) and ginkgolide B (GB).
18     Ginkgolide C is 25-fold less potent than ginkgolide B as a PAF receptor antagonist, due to the pr
19 ein we describe the synthesis of a series of ginkgolide B derivatives with modifications at the 7-pos
20 thermore, standard reduction of 7alpha-azido ginkgolide B did not give the expected primary amine, bu
21 es nucleophilic attack on a 7beta-O-triflate ginkgolide B did not lead to the expected products, but
22 d PAF receptor, confirming that of the TTLs, ginkgolide B is the most potent PAF receptor antagonist.
23 7alpha-fluoro ginkgolide B was equipotent to ginkgolide B underlining the critical importance of the
24        Recently, we found that 7alpha-fluoro ginkgolide B was equipotent to ginkgolide B underlining
25                    Conversely, vitamin C and ginkgolide B were not efficient quenchers of singlet oxy
26 tivating factor receptor (PafR) antibody and Ginkgolide B, a well-defined PafR antagonist, demonstrat
27 ta-substituents, in particular 7alpha-chloro ginkgolide B, the most potent nonaromatic ginkgolide der
28 locked when platelets were preincubated with Ginkgolide B.
29 antibodies against PAFR and PAFR antagonist, ginkgolide B.
30 harmacologically active terpene trilactones (ginkgolides, bilobalide) from the tissues of Ginkgo bilo
31                                              Ginkgolides, but not vitamin E, inhibited the Abeta-indu
32 hese acetylations have given rise to various ginkgolide C acetates and iso-ginkgolide C acetates, the
33 ise to various ginkgolide C acetates and iso-ginkgolide C acetates, the latter having a rearranged sk
34 ective acetylation of the hydroxyl groups of ginkgolide C have been developed.
35                                              Ginkgolide C is 25-fold less potent than ginkgolide B as
36 ro ginkgolide B, the most potent nonaromatic ginkgolide derivative described to date with a K(i) valu
37                                              Ginkgolide derivatives carrying photoactivatable and flu
38                                              Ginkgolide derivatives incorporating both fluorescent an
39                These studies have shown that ginkgolide derivatives with aromatic photoactivatable su
40 products, but gave rise to two unprecedented ginkgolide derivatives, one with a novel rearranged skel
41 the critical importance of the 7-position of ginkgolides for PAF receptor activity.
42                                         Four ginkgolides (GA, GB, GC, GJ) and bilobalide (BB) from bo
43 e GABA(A) receptor alpha-subunits, decreases ginkgolide potency by up to 10,000-fold.
44      Pretreatment of the cells with isolated ginkgolides, the anti-oxidant component of Ginkgo biloba
45 ellent ligands for clarifying the binding of ginkgolides to PAF receptor by photolabeling studies.
46 esting with cloned PAF receptors showed that ginkgolides with 7alpha-substitutents had increased affi

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。